These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25689055)

  • 1. Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assay.
    Moraschini L; Passalacqua I; Fabbrini M; Margarit Y Ros I; Rigat F
    Pharm Stat; 2015; 14(3):189-97. PubMed ID: 25689055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an opsonophagocytic killing assay for group a streptococcus.
    Jones S; Moreland NJ; Zancolli M; Raynes J; Loh JMS; Smeesters PR; Sriskandan S; Carapetis JR; Fraser JD; Goldblatt D
    Vaccine; 2018 Jun; 36(26):3756-3763. PubMed ID: 29776751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A four-parameter logistic model for estimating titers of functional multiplexed pneumococcal opsonophagocytic killing assay.
    Wang D; Burton RL; Nahm MH; Soong SJ
    J Biopharm Stat; 2008; 18(2):307-25. PubMed ID: 18327723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of A Standardized Opsonophagocytosis Killing Assay for Group B
    Leung S; Collett CF; Allen L; Lim S; Maniatis P; Bolcen SJ; Alston B; Patel PY; Kwatra G; Hall T; Thomas S; Taylor S; Le Doare K; Gorringe A
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional analysis of HL-60 cells used in opsonophagocytic-killing assay for Streptococcus pneumoniae.
    Kim KH; Seoh JY; Cho SJ
    J Korean Med Sci; 2015 Feb; 30(2):145-50. PubMed ID: 25653484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonophagocytic Killing Assay to Measure Anti-Group A Streptococcus Antibody Functionality in Human Serum.
    Wagstaffe H; Jones S; Johnson M; Goldblatt D
    Methods Mol Biol; 2022; 2414():373-386. PubMed ID: 34784047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
    Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
    J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activity of class-specific antibodies to type III, group B streptococcus.
    Campbell JR; Baker CJ; Metzger TG; Edwards MS
    Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
    Fine DP; Kirk JL; Schiffman G; Schweinle JE; Guckian JC
    J Lab Clin Med; 1988 Oct; 112(4):487-97. PubMed ID: 3171357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
    N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae.
    Johnson SE; Rubin L; Romero-Steiner S; Dykes JK; Pais LB; Rizvi A; Ades E; Carlone GM
    J Infect Dis; 1999 Jul; 180(1):133-40. PubMed ID: 10353871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III.
    Lancaster L; Saydam M; Markey K; Ho MM; Mawas F
    Vaccine; 2011 Apr; 29(17):3213-21. PubMed ID: 21356338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    Baltimore RS; Kasper DL; Baker CJ; Goroff DK
    J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
    Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
    J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
    Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
    Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
    J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
    Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
    J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine antibody against Streptococcus agalactiae, type Ia, produced by preparturient intramammary and systemic vaccination.
    Yokomizo Y; Norcross NL
    Am J Vet Res; 1978 Mar; 39(3):511-6. PubMed ID: 345893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.